Revvity The Alphalisa® Immunoassay Kit For Human

Revvity Formats: - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Our 100 assay point kit allows you to run 100 wells in 96-well format, using a 100 µL reaction volume (10 µL of sample). Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample). Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).

Revvity AlphaLISA features: - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

No-wash steps, no separation steps ELISA alternative technology Sensitive detection Broad sample compatibility Small sample volume Results in less than 3 hours Half the time of an ELISA assay

Revvity AlphaLISA technology allows the detection of molecules of interest in buffer, cell culture media, serum and plasma in a highly sensitive, quantitative, reproducible and user-friendly mode. In an AlphaLISA assay, a Biotinylated Anti-Analyte Antibody binds to the Streptavidin-coated Alpha Donor beads, while another Anti-Analyte Antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads provokes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity TNF-related apoptosis-inducing ligand (TRAIL) is a type II transmembrane protein expressed on the cell surface that is also known as tumor necrosis factor superfamily 10 (TNFSF10). This transmembrane protein can be cleaved by cysteine proteinases at the surface, which in turn generates the soluble form of TRAIL. TRAIL has a molecular weight of approximately 24-28 kDa and functions as a ligand, inducing the process of cell death primarily in tumor cells by binding to certain death receptors. TRAIL and its receptors are currently used for several anti-cancer therapeutics and is involved in the pathophysiological processes of cardiovascular and metabolic diseases. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)